CLINICAL TRIAL
Treatment for Tinnitus
Waitlist Available · 18+ · All Sexes · Washington, United States
This study is evaluating whether a device that helps people with tinnitus hear better can help people with tinnitus hear better.
See full descriptionAbout the trial for Tinnitus
Treatment Groups
This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.
Placebo
DEVICE
Otoband
DEVICE
Eligibility
This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.
Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:View All
Male or female subjects age 18 to 70 years old
Tinnitus that has been present for at least 90 days
Tinnitus that is constant or predictable
Computer and access to internet for online video conference
Score greater than or equal to 36 on the Tinnitus Handicap Questionnaire
Access to a PayPal, Venmo account to receive compensation
Odds of EligibilitySimilar Trials
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Approximate Timelines
Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Device use log over two week period of use by the study participant
Screening: ~3 weeks
Treatment: Varies
Reporting: Device use log over two week period of use by the study participant
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like
Measurement Requirements
This trial is evaluating whether Treatment will improve 1 primary outcome and 2 secondary outcomes in patients with Tinnitus. Measurement will happen over the course of Device use log over two week period of use by the study participant.
Identification of a preferred power level for tinnitus as determined by Otoband device log.
DEVICE USE LOG OVER TWO WEEK PERIOD OF USE BY THE STUDY PARTICIPANTDEVICE USE LOG OVER TWO WEEK PERIOD OF USE BY THE STUDY PARTICIPANT
Identification of a preferred power level for tinnitus as determined by the power level that participants use for the longest cumulative use throughout the study.Change in bothersomeness of Tinnitus as measured by Tinnitus Handicap Questionnaire
FORMS FILLED OUT DAILY OVER TWO WEEK PERIOD BY THE STUDY PARTICIPANTFORMS FILLED OUT DAILY OVER TWO WEEK PERIOD BY THE STUDY PARTICIPANT
The primary endpoint will be the change in THQ score of a participant while wearing an effective device versus the THQ score at enrollment/baseline.Change in Quality of Life Measures as measured by the Tinnitus Handicap Questionnaire
FORMS FILLED OUT DAILY OVER TWO WEEK PERIOD BY THE STUDY PARTICIPANTFORMS FILLED OUT DAILY OVER TWO WEEK PERIOD BY THE STUDY PARTICIPANT
Change in Quality of Life Measures at the conclusion of the study versus the start of enrollment as measured by the Tinnitus Handicap Questionnaire.Patient Q & A Section
Ask a question about the study
Other questions from users
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any geographic restrictions to consider when applying for this trial?
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
Will my insurance cover participating in this trial?
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.
See if you qualify for this trial
Get access to this novel treatment for Tinnitus by sharing your contact details with the study coordinator.